Effectiveness of fluoxetine on various subtypes of obsessive-compulsive disorder

Archives of Iranian Medicine

Volumn 11, Issue 5, 2008, Pages 522-525

  Farnam, Alireza ^a   Gorcishizadeh, Mohammad Ali ^a   Farhang, Sara ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clinical subtype; Fluoxetine; Obsessive compulsive disorder

Indexed keywords

FLUOXETINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HAND WASHING; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; RATING SCALE; TREATMENT DURATION; TREATMENT OUTCOME;

FEMALE; FLUOXETINE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS;

EID: 63449111195     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kaplan H, Sadock B. Kaplan and Sadock's Synopsis of Psychiatry. 8th ed. Baltimore, Meryland: Williams and Wilkins; 2003: 609-617.
2. Sadock B, Sadock V. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 7th ed. Vol 1. Phildelphia: Lippincott Williams and Wilkins; 2000: 1441-1503.
3. McDougle CJ, Epperson CN, Price LH, Gelevnter J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive-compulsive disorder. Mol Psychiatry. 1998; 3: 270-273.
4. Etain B, Bonnet-Perrin E. Value of fluoxetine in obsessive-compulsive disorder in the adults: review of the literature. Encephale. 2001; 27: 280-289.
5. Meltzer H, Bastani B, Jayathilake K, Maes M. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive-compulsive disorder. Neuropsychopharmacology. 1997; 17: 1-11.
6. Montgomery SA, McIntyre A, Osterheider M, Sarteschi P, Zitterl W, Zohar J, et al. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group. Eur Neuropsychopharmacol. 1993; 3: 143-152.
7. Warnock JK, Kestenbaum T. Obsessive-compulsive disorder. Dermatol Clin. 1996; 14: 465-472.
8. Rufer M, Fricke S, Moritz S, Kloss M, Hand I. Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome. Acta Psychiatr Scand. 2006; 113: 440-446.
9. Abramowitz JS, Franklin ME, Schwartz SA, Furr JM. Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. J Consult Clin Psychol. 2003; 71: 1049-1057.
10. Soomro GM. Sertraline reduced patient dropout rates and acute exacerbation of symptoms in obsessive-compulsive disorder. Evid Based Ment Health. 2002; 5: 115.
11. Alonso P, Menchon JM, Pifarre J, Mataix-Cols D, Torres L, Salgado P, et al. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry. 2001; 62: 535-540.
12. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry. 1997; 154: 911-917.
13. Matsunaga H, Kiriike N, Miyata A, Iwasaki Y, Matsui T, Nagata T, et al. Personality disorders in patients with obsessive-compulsive disorder in Japan. Acta Psychiatrica Scandinavica. 1998; 98: 128-134.
14. Rasmussen SA, Eisen JL. The epidemiology and clinical features of obsessive-compulsive disorder. Psychiatric Clinic North Am. 1992; 15: 743-758.
15. Rauch SL, Dougherty DD, Shin LM, Alpert NM, Manzo P, Leahy L. Neural correlates of factor-analyzed OCD symptom dimensions: a PET study. CNS Spectrums. 1998; 3: 37-48.
16. Horesh N, Dolberg OT, Kirschenbaum-Aviner N, Kotler M. Personality differences between obsessive-compulsive disorder subtypes: washers versus checkers. Psychiatry Res. 1997; 71: 197-200.
17. Gibbs NA, Oltmanns TF. The relation between obsessive-compulsive personality traits and subtypes of compulsive behavior. J Anxiety Dis. 1995; 9: 397-410.
18. Basoglu M, Lax T, Kasvikis Y, Marks IM. Predictors of improvement in obsessive-compulsive disorder. J Anxiety Dis. 1988; 2: 299-317.
19. Buchanan AW, Meng KS, Marks IM. What predicts improvement and compliance during the behavioral treatment of obsessive-compulsive disorder? Anxiety. 1996; 2: 22-27.
20. Drummond LM. The treatment of severe, chronic, resistant obsessive- compulsive disorder. An evaluation of an in-patient program using behavioral psychotherapy in combination with other treatments. Br J Psychiatry. 1993; 163: 223-229.